QAMZOVA Trademark

Trademark Overview


On Thursday, February 27, 2025, a trademark application was filed for QAMZOVA with the United States Patent and Trademark Office. The USPTO has given the QAMZOVA trademark a serial number of 99060475. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, August 5, 2025. This trademark is owned by NANJING DELOVA BIOTECH CO., LTD.. The QAMZOVA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines made of Chinese traditional medicinal herbs; Medicines for human purposes in the nature of pain relief medications; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; Pre-filled syringes for medical purposes sold fill...
qamzova

General Information


Serial Number99060475
Word MarkQAMZOVA
Filing DateThursday, February 27, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, August 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines made of Chinese traditional medicinal herbs; Medicines for human purposes in the nature of pain relief medications; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for skin care, skin regeneration, skin moisturization, and aesthetic skin treatments to treat skin disorders; Pre-filled syringes for medical purposes sold filled with hyaluronic acid and Botulinum toxin; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports related injuries, cerebral palsy, muscle spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for blood infusions, pharmaceutical preparations, specifically, dantrolene sodium for injections, and emergency pharmaceutical preparations containing diluents and active pharmaceutical ingredients for the treatment of wounds; Analgesics; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Dietetic foods adapted for medical purposes; Medicines for veterinary purposes for the treatment of infectious diseases, viral conditions, skin conditions, pain, and inflammation; First aid kits; First-aid boxes, filled

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNANJING DELOVA BIOTECH CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNanjing, Jiangsu 211112
CN

Trademark Events


Event DateEvent Description
Thursday, February 27, 2025NEW APPLICATION ENTERED
Thursday, February 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 27, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, June 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 10, 2025NON-FINAL ACTION E-MAILED
Monday, August 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 2, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN